In pneumonia, asthma, hepatitis, and kidney injury diseases, luteolin can exert its biological activities by blocking the PI3K‐Akt and p53 signaling pathways [16, 17, 18, 24, 25, 26, 43, 44]. This evidence concerns the gene AKT1 and susceptibility to pneumonia measurement.